CDK7 Inhibitor therapy(1cBio)

N/A

Report date: 2025/02/18 17:45:03

NME

Base Information

Drug NameCDK7 Inhibitor therapy(1cBio)

Drug Alias NameOC-3(1cBio)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCyclin-dependent kinase 7 inhibitors

TargetsCyclin-dependent kinase 7

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator Companies1cBio Inc

China Registration ClassN/A

Active Companies1cBio Inc

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

ATC CodeN/A